--- title: Peak Partners - TD2 Precision Oncology description: TD2's Peak Partners program is a growing alliance of high-performing research sites committed to operational excellence and innovation in oncology clinical trials. --- ×   [![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en) ![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png) [![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en) ![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)   # Peak Partners ## Reaching New Heights, Together Our Peak Partners program is a growing alliance of high-performing research sites committed to operational excellence and innovation in oncology clinical trials. Built to foster collaboration, accelerate timelines, and strengthen communication, Peak Partners unites global community sites, hospitals, academic centers, and site networks through a shared vision: advancing oncology breakthroughs, together. #### Why Join Peak Partners? Strong alliances between CROs and sites lead to: - Faster start-up timelines - More effective protocol design - Quicker resolution of trial obstacles - Better outcomes for patients TD2 is proud to champion these outcomes through meaningful, long-term site relationships. ![](https://td2inc.com/hs-fs/hubfs/benefits.png?width=800&name=benefits.png) ### Join Our Peak Partners Program Contact us today to get started. #### Built on Trusted Relationships TD2’s Peak Partners program is led by experienced site services professionals with deep roots in site engagement—including published insights on site-CRO collaboration in the *SCRS Insite Journal*. We believe in meaningful partnerships that elevate the research experience—for both sites and sponsors. ### “We know that great sites are the foundation of every successful oncology trial. Peak Partners is our way of honoring and strengthening that partnership.” ![](https://td2inc.com/hs-fs/hubfs/peak-partners-seal.png?width=250&name=peak-partners-seal.png) ## Additional Resources [![Challenges in Radiopharmaceutical Development for Oncology Therapies](https://td2inc.com/hubfs/radiopharmaceutical-development.jpg)](https://blog.td2inc.com/challenges-in-radiopharmaceutical-development-for-oncology-therapies?hsLang=en) Clinical ## [Challenges in Radiopharmaceutical Development for Oncology Therapies](https://blog.td2inc.com/challenges-in-radiopharmaceutical-development-for-oncology-therapies?hsLang=en) [![Emerging Trends in Radiopharmaceuticals](https://td2inc.com/hubfs/radiopharmaceuticals.jpg)](https://blog.td2inc.com/emerging-trends-in-radiopharmaceuticals?hsLang=en) Clinical ## [Emerging Trends in Radiopharmaceuticals](https://blog.td2inc.com/emerging-trends-in-radiopharmaceuticals?hsLang=en) Load More ![Clinical Study Management](https://td2inc.com/hs-fs/hubfs/Assets/Icon/icon-clinical-study-management.png?width=101&height=85&name=icon-clinical-study-management.png) ### Comprehensive # Clinical Trial Services Include: - [Study design & protocol development](https://td2inc.com/protocol-design/?hsLang=en) - [Patient identification and site engagement](https://td2inc.com/lp-patient-identification-and-site-engagement/?hsLang=en) - [Site management and monitoring](https://td2inc.com/comprehensive-site-management-and-monitoring?hsLang=en) - [Third-party vendor management](https://td2inc.com/strategic-third-party-vendor-management?hsLang=en) - [Biostatistics](https://td2inc.com/biostatistics?hsLang=en) **Therapeutic Areas:** - [Radiolabeled Pharmaceuticals](https://td2inc.com/clinical-trial-services-for-radiolabeled-pharmaceuticals?hsLang=en) - [Hematologic Malignancies](https://td2inc.com/comprehensive-clinical-trial-services-for-hematologic-malignancies?hsLang=en) - [Antibody-Drug Conjugates](https://td2inc.com/clinical-trial-services-for-antibody-drug-conjugates?hsLang=en) - [Small Molecules](https://td2inc.com/clinical-trial-services-for-small-molecules?hsLang=en) - [Data management](https://td2inc.com/lp-data-management/?hsLang=en) - [Clinical Flow Cytometry](https://td2inc.com/lp-clinical-flow-cytometry/?hsLang=en) - [Pharmacovigilance](https://td2inc.com/pharmacovigilance?hsLang=en) - [Medical monitoring](https://td2inc.com/medical-monitoring-services?hsLang=en) - [eTMF management](https://td2inc.com/etmf-management-services?hsLang=en) - [Quality Assurance](https://td2inc.com/quality-assurance-services?hsLang=en) ## GET STARTED ## Put your clinical trial in the hands of a team who believes in your research as much as you do. Are you ready to start your preclinical trial? Partner with a collaborative oncology CRO that believes in your treatment as much as you do. Take the first step today and contact our experts. [Get Started Now](https://td2inc.com/contact-us/?hsLang=en) [![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/td2-logo.png?width=160&name=td2-logo.png)](https://td2inc.com/?hsLang=en) Office 13208 E. Shea Blvd, Suite 100 Scottsdale, AZ 85259 Phone (602) 358-8300 Connect with us - - ![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/Assets/Logo/acclac-logo.png?width=139&name=acclac-logo.png) © 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)